State-of-the-Art PaperThe Advancing Clinical Impact of Molecular Imaging in CVD
Under an Elsevier user license
open archive
Key Words
aneurysm
atherosclerosis
heart failure
molecular imaging
myocardial infarction
thrombosis
valvular disease
vascular injury
Abbreviations and Acronyms
158Gd-ESMA
gadolinium-labeled elastin-specific magnetic resonance contrast agent
AS
aortic stenosis
AT1R
angiotensin II type 1 receptor
CAC
coronary artery calcium
CEA
carotid endarterectomy
CMR
cardiac magnetic resonance
CT
computed tomography
DVT
deep vein thrombosis
FDA
Food and Drug Administration
FDG
18F-fluorodeoxyglucose
hsCRP
high-sensitivity C-reactive protein
ICG
indocyanine green
LDL
low-density lipoprotein
LV
left ventricle/ventricular
MI
myocardial infarction
MMP
matrix metalloproteinase
MRI
magnetic resonance imaging
NaF
18F-sodium fluoride
NIRF
near-infrared fluorescence
OFDI
optical frequency domain imaging
OTW
over-the-wire
PC
perfusion catheter
PET
positron emission tomography
RAAS
renin-angiotensin-aldosterone system
SUV
standardized uptake value
TBR
target-to-background ratio
USPIO
ultrasmall superparamagnetic particles of iron oxide
Cited by (0)
Funded by a National Institutes of Health grant R01 HL108229, American Heart Association Scientist Development Grant #0830352N and Grant-in-Aid #13GRNT1760040, and NIH T32 HL007374 support for Dr. Osborn. Dr. Jaffer has received research funding from Abbott Vascular, Merck & Co., and Kowa Company, Ltd.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.